A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Breast Cancer
Interventions: DRUG: AND019 PO QD
Sponsor: Kind Pharmaceuticals LLC